Brief: Sight Sciences Inc - Has Exposure To Tariffs Imposed By The U.S. On China Because Most Of Its Products Are Produced And Assembled In China
Nov 7 (Reuters) - Sight Sciences Inc SGHT.O: SIGHT SCIENCES INC - HAS EXPOSURE TO TARIFFS IMPOSED BY THE U.S. ON CHINA BECAUSE MOST OF ITS PRODUCTS ARE PRODUCED AND ASSEMBLED IN CHINA SIGHT SCIENCES- EXPECT SURGICAL GLAUCOMA SEGMENT’S TARIFF EXPOSURE TO INCREASE SEGMENT’S COST OF GOODS SOLD BY BETWEEN $1.0 MILLION - $1.5 MILLION FOR 2025 Source text: [ID:n0001193125-25-269525] Further company coverage: SGHT.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Sight Sciences
See all newsSight Sciences raises FY 2026 revenue outlook
Brief: Sight Sciences Q1 Revenue USD 19.7 Million Vs. IBES Estimate USD 18.5 Million
Brief: Sight Sciences U.S. District Court Issued Order On Post-Trial Motions In Patent Infringement Case Against Alcon Originally Filed On Sep 16, 2021
Sight Sciences Q4 revenue rises 7%
Brief: Sight Sciences Announces Preliminary, Unaudited Fourth Quarter And Full Year 2025 Financial Highlights